Thivya Balendran1, Lalani Yatawara2, Susiji Wickramasinghe3. 1. Department of Parasitology, Faculty of Medicine, University of Peradeniya, Peradeniya, Sri Lanka. 2. Department of Medical Laboratory Science, Faculty of Allied Health Sciences, University of Peradeniya, Peradeniya, Sri Lanka. 3. Department of Parasitology, Faculty of Medicine, University of Peradeniya, Peradeniya, Sri Lanka. susijij@pdn.ac.lk.
Abstract
PURPOSE: Sri Lanka has reported the highest prevalence of human dirofilariasis cases in Asia. Thus far, Dirofilaria repens is the only reported Dirofilaria species that affect humans, dogs, and cats in Sri Lanka. Therefore, this systematic review was carried out to analyse the studies performed on dirofilariasis in Sri Lanka. METHODS: Peer-reviewed articles were searched on dirofilariasis published on Google Scholar, PubMed, Cochrane, and ResearchGate from January to March 2021. Articles were selected using inclusion and exclusion criteria. Three reviewers assessed the studies and extracted data independently to minimize the risk of bias. Extracted data were compiled, and then the results were compared and discussed in this systematic review. RESULTS: Twenty-five studies performed in Sri Lanka were analysed, and high prevalence areas, frequent clinical presentations, diagnostic methods, reservoir hosts, and treatment were identified. More than 173 cases of human dirofilariasis caused by D. repens were reported from 1962 to 2020 in 20 districts among 25 investigated. The highest number of cases (n = 80) was recorded during 2010-2012 period. Canine and feline dirofilariasis are reported countrywide, and a large number of potential mosquito breeding sites could be seen in Sri Lanka. CONCLUSIONS: The number of reported cases of human dirofilariasis has been varied from 1962 to 2020. The highest number of cases has reported in 2010-2012, and then the number of cases has dropped. This may be due to underreporting. Thus, awareness of Dirofilaria repens infection in humans, control measures in endemic areas and further research on dirofilariasis in other districts of Sri Lanka are crucial.
PURPOSE: Sri Lanka has reported the highest prevalence of human dirofilariasis cases in Asia. Thus far, Dirofilaria repens is the only reported Dirofilaria species that affect humans, dogs, and cats in Sri Lanka. Therefore, this systematic review was carried out to analyse the studies performed on dirofilariasis in Sri Lanka. METHODS: Peer-reviewed articles were searched on dirofilariasis published on Google Scholar, PubMed, Cochrane, and ResearchGate from January to March 2021. Articles were selected using inclusion and exclusion criteria. Three reviewers assessed the studies and extracted data independently to minimize the risk of bias. Extracted data were compiled, and then the results were compared and discussed in this systematic review. RESULTS: Twenty-five studies performed in Sri Lanka were analysed, and high prevalence areas, frequent clinical presentations, diagnostic methods, reservoir hosts, and treatment were identified. More than 173 cases of human dirofilariasis caused by D. repens were reported from 1962 to 2020 in 20 districts among 25 investigated. The highest number of cases (n = 80) was recorded during 2010-2012 period. Canine and feline dirofilariasis are reported countrywide, and a large number of potential mosquito breeding sites could be seen in Sri Lanka. CONCLUSIONS: The number of reported cases of human dirofilariasis has been varied from 1962 to 2020. The highest number of cases has reported in 2010-2012, and then the number of cases has dropped. This may be due to underreporting. Thus, awareness of Dirofilaria repens infection in humans, control measures in endemic areas and further research on dirofilariasis in other districts of Sri Lanka are crucial.
Authors: Fernando Simón; Mar Siles-Lucas; Rodrigo Morchón; Javier González-Miguel; Isabel Mellado; Elena Carretón; Jose Alberto Montoya-Alonso Journal: Clin Microbiol Rev Date: 2012-07 Impact factor: 26.132
Authors: T G A N Chandrasena; R Premaratna; C H Mallawaarachchi; N K Gunawardena; P A D H N Gunathilaka; W Y Abeyewickrama; N R de Silva Journal: Biomed Res Int Date: 2019-04-18 Impact factor: 3.411